Objective To report the retention rate of the Boston Keratoprosthesis Type 1 and to identify risk factors for keratoprosthesis loss. Design Cohort study. Participants 300 eyes of 300 patients who underwent implantation of a Boston Keratoprosthesis Type I device between January 2003 and July 2008 by one of 19 surgeons at 18 medical centers. Methods Forms reporting preoperative, intraoperative, and postoperative parameters were prospectively collected and subsequently analyzed at a central data collection site. Main Outcome Measures Keratoprosthesis retention. Results A total cumulative number of 422 life years of device implantation are included in this analysis. The average duration of follow up was 17.1 ± 14.8 months with a range of one week to over 6.1 years. 93% of the 300 Boston Keratoprosthesis implanted were retained at their last follow up, corresponding to a retention time of 396 patient-years or 1.42 years / keratoprosthesis. The probability of retention after one year and two years was 94% and 89%, respectively. During the study period, 21 (7%) keratoprosthesis implants failed to retain the device; the reasons for keratoprosthesis loss include sterile keratolysis (9), fungal infections (8), dense retroprosthetic membranes (3), and bacterial endophthalmitis (1). Multivariate analysis demonstrated three independent risk factors for keratoprosthesis loss: autoimmune etiology (hazard ratio [HR] = 11.94; 95% confidence interval [CI] 3.31, 43.11), ocular surface exposure requiring a concomitant tarsorrhaphy (HR = 3.43; 95% CI 1.05, 11.22) and number of prior failed penetrating keratoplasties (HR = 1.64; 95% CI 1.18, 2.28). Conclusions The Boston Type 1 Keratoprosthesis appears to be a viable option for eyes that are not candidates for penetrating keratoplasty. Ocular surface disease due to an autoimmune etiology demonstrated the lowest retention rate.

Intracameral cefuroxime and moxifloxacin reduced endophthalmitis rates compared with controls with minimal or no toxicity events at standard doses. Additionally, intracameral antibiotics alone may be as effective as intracameral plus topical antibiotics.

No abstract

No abstract

Vitrectomy for macular detachment due to optic disk pit has good long-term success and results in an improvement in visual acuity. However, adjuvant techniques such as internal limiting membrane peel and temporal endolaser may not improve outcomes, nor does there seem to be a difference between short- and long-acting gases. Patients should be made aware that it can take more than a year and multiple surgeries to achieve foveal reattachment and that increased baseline central retinal thickness is a poor prognostic sign.